APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alpha-1 Antitrypsin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alpha-1 Antitrypsin Drugs Market Analysis and Forecast 2026-2032

Report ID 173962200220 December 2025197 pages

Choose your research edition.

Industry ResearchAlpha-1 Antitrypsin Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha-1 Antitrypsin Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Alpha-1 Antitrypsin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha-1 Antitrypsin Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha-1 Antitrypsin Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alpha-1 Antitrypsin Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alpha-1 Antitrypsin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alpha-1 Antitrypsin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alpha-1 Antitrypsin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alpha-1 Antitrypsin Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Alpha-1 Antitrypsin Drugs include Baxter, Kamada, Grifols, CSL Behring, Baxalta, Arrowhead Research Corporation, Applied Genetic Technologies Corp, Alnylam Pharmaceuticals and Abeona Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alpha-1 Antitrypsin Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alpha-1 Antitrypsin Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Alpha-1 Antitrypsin Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alpha-1 Antitrypsin Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alpha-1 Antitrypsin Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alpha-1 Antitrypsin Drugs sales, projected growth trends, production technology, application and end-user industry.

Alpha-1 Antitrypsin Drugs Segment by Company

Baxter

Kamada

Grifols

CSL Behring

Baxalta

Arrowhead Research Corporation

Applied Genetic Technologies Corp

Alnylam Pharmaceuticals

Abeona Therapeutics

Alpha-1 Antitrypsin Drugs Segment by Type

Parenteral

Inhalation

Alpha-1 Antitrypsin Drugs Segment by Application

Drugstore

Hospital

Others

Alpha-1 Antitrypsin Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha-1 Antitrypsin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha-1 Antitrypsin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha-1 Antitrypsin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alpha-1 Antitrypsin Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alpha-1 Antitrypsin Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alpha-1 Antitrypsin Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Parenteral Major Manufacturers Table 3. Inhalation Major Manufacturers Table 4. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Drugstore Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Others Major Manufacturers Table 8. Alpha-1 Antitrypsin Drugs Industry Trends Table 9. Alpha-1 Antitrypsin Drugs Industry Drivers Table 10. Alpha-1 Antitrypsin Drugs Industry Opportunities and Challenges Table 11. Alpha-1 Antitrypsin Drugs Industry Restraints Table 12. Global Alpha-1 Antitrypsin Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Alpha-1 Antitrypsin Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Alpha-1 Antitrypsin Drugs Sales by Region (2021-2026) & (W Units) Table 19. Global Alpha-1 Antitrypsin Drugs Sales by Region (2027-2032) & (W Units) Table 20. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2021-2026) Table 21. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2027-2032) Table 22. Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Alpha-1 Antitrypsin Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Alpha-1 Antitrypsin Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Alpha-1 Antitrypsin Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Alpha-1 Antitrypsin Drugs Manufacturers, Product Type & Application Table 30. Global Alpha-1 Antitrypsin Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Alpha-1 Antitrypsin Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Alpha-1 Antitrypsin Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Alpha-1 Antitrypsin Drugs Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 40. Global Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 41. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2021-2026) Table 42. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2027-2032) Table 43. Global Alpha-1 Antitrypsin Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Alpha-1 Antitrypsin Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Alpha-1 Antitrypsin Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Alpha-1 Antitrypsin Drugs Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 52. Global Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 53. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2021-2026) Table 54. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2027-2032) Table 55. Global Alpha-1 Antitrypsin Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Alpha-1 Antitrypsin Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Baxter Company Information Table 58. Baxter Business Overview Table 59. Baxter Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Baxter Alpha-1 Antitrypsin Drugs Product Portfolio Table 61. Baxter Recent Development Table 62. Kamada Company Information Table 63. Kamada Business Overview Table 64. Kamada Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Kamada Alpha-1 Antitrypsin Drugs Product Portfolio Table 66. Kamada Recent Development Table 67. Grifols Company Information Table 68. Grifols Business Overview Table 69. Grifols Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Grifols Alpha-1 Antitrypsin Drugs Product Portfolio Table 71. Grifols Recent Development Table 72. CSL Behring Company Information Table 73. CSL Behring Business Overview Table 74. CSL Behring Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolio Table 76. CSL Behring Recent Development Table 77. Baxalta Company Information Table 78. Baxalta Business Overview Table 79. Baxalta Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Baxalta Alpha-1 Antitrypsin Drugs Product Portfolio Table 81. Baxalta Recent Development Table 82. Arrowhead Research Corporation Company Information Table 83. Arrowhead Research Corporation Business Overview Table 84. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolio Table 86. Arrowhead Research Corporation Recent Development Table 87. Applied Genetic Technologies Corp Company Information Table 88. Applied Genetic Technologies Corp Business Overview Table 89. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolio Table 91. Applied Genetic Technologies Corp Recent Development Table 92. Alnylam Pharmaceuticals Company Information Table 93. Alnylam Pharmaceuticals Business Overview Table 94. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolio Table 96. Alnylam Pharmaceuticals Recent Development Table 97. Abeona Therapeutics Company Information Table 98. Abeona Therapeutics Business Overview Table 99. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolio Table 101. Abeona Therapeutics Recent Development Table 102. North America Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Alpha-1 Antitrypsin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 105. North America Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 106. North America Alpha-1 Antitrypsin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Alpha-1 Antitrypsin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Alpha-1 Antitrypsin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 111. North America Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 112. North America Alpha-1 Antitrypsin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Alpha-1 Antitrypsin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 118. North America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 119. North America Alpha-1 Antitrypsin Drugs Sales by Country (2027-2032) & (W Units) Table 120. North America Alpha-1 Antitrypsin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Alpha-1 Antitrypsin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 123. Canada Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 124. Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 127. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 128. Europe Alpha-1 Antitrypsin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe Alpha-1 Antitrypsin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 133. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 134. Europe Alpha-1 Antitrypsin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe Alpha-1 Antitrypsin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 140. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 141. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2027-2032) & (W Units) Table 142. Europe Alpha-1 Antitrypsin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe Alpha-1 Antitrypsin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 145. France Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 146. U.K. Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 147. Italy Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 149. China Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 150. China Alpha-1 Antitrypsin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 151. China Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 152. China Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 153. China Alpha-1 Antitrypsin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 154. China Alpha-1 Antitrypsin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 155. China Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 156. China Alpha-1 Antitrypsin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 157. China Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 158. China Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 159. China Alpha-1 Antitrypsin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 160. China Alpha-1 Antitrypsin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Alpha-1 Antitrypsin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 164. Asia Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 165. Asia Alpha-1 Antitrypsin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Asia Alpha-1 Antitrypsin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Asia Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Alpha-1 Antitrypsin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 170. Asia Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 171. Asia Alpha-1 Antitrypsin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Asia Alpha-1 Antitrypsin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 177. Asia Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 178. Asia Alpha-1 Antitrypsin Drugs Sales by Country (2027-2032) & (W Units) Table 179. Asia Alpha-1 Antitrypsin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Asia Alpha-1 Antitrypsin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Japan Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 182. South Korea Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 183. India Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 184. Australia Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 185. China Taiwan Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Alpha-1 Antitrypsin Drugs Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (W Units) Table 190. SAMEA Alpha-1 Antitrypsin Drugs Sales by Type (2027-2032) & (W Units) Table 191. SAMEA Alpha-1 Antitrypsin Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 192. SAMEA Alpha-1 Antitrypsin Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 193. SAMEA Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Alpha-1 Antitrypsin Drugs Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (W Units) Table 196. SAMEA Alpha-1 Antitrypsin Drugs Sales by Application (2027-2032) & (W Units) Table 197. SAMEA Alpha-1 Antitrypsin Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 198. SAMEA Alpha-1 Antitrypsin Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 199. SAMEA Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 203. SAMEA Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (W Units) Table 204. SAMEA Alpha-1 Antitrypsin Drugs Sales by Country (2027-2032) & (W Units) Table 205. SAMEA Alpha-1 Antitrypsin Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 206. SAMEA Alpha-1 Antitrypsin Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Brazil Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 208. Argentina Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 209. Chile Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 210. Colombia Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 211. Peru Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 213. Israel Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 214. UAE Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 215. Turkey Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 216. Iran Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 217. Egypt Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Alpha-1 Antitrypsin Drugs Distributors List Table 221. Alpha-1 Antitrypsin Drugs Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Alpha-1 Antitrypsin Drugs Image Figure 2. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha-1 Antitrypsin Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Parenteral Image Figure 5. Inhalation Image Figure 6. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Alpha-1 Antitrypsin Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Drugstore Image Figure 9. Hospital Image Figure 10. Others Image Figure 11. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Alpha-1 Antitrypsin Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Alpha-1 Antitrypsin Drugs Sales (2021-2032) & (W Units) Figure 17. Global Alpha-1 Antitrypsin Drugs Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Alpha-1 Antitrypsin Drugs Sales YoY (2021-2032) & (W Units) Figure 20. Europe Alpha-1 Antitrypsin Drugs Sales YoY (2021-2032) & (W Units) Figure 21. China Alpha-1 Antitrypsin Drugs Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Alpha-1 Antitrypsin Drugs Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Alpha-1 Antitrypsin Drugs Sales YoY (2021-2032) & (W Units) Figure 24. Global Alpha-1 Antitrypsin Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Alpha-1 Antitrypsin Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Alpha-1 Antitrypsin Drugs Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Alpha-1 Antitrypsin Drugs Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Alpha-1 Antitrypsin Drugs Revenue Share by Type (2021-2032) Figure 40. North America Alpha-1 Antitrypsin Drugs Sales Share by Type (2021-2032) Figure 41. North America Alpha-1 Antitrypsin Drugs Revenue Share by Application (2021-2032) Figure 42. North America Alpha-1 Antitrypsin Drugs Sales Share by Application (2021-2032) Figure 43. North America Alpha-1 Antitrypsin Drugs Revenue Share by Country (2021-2032) Figure 44. North America Alpha-1 Antitrypsin Drugs Sales Share by Country (2021-2032) Figure 45. Europe Alpha-1 Antitrypsin Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Alpha-1 Antitrypsin Drugs Sales Share by Type (2021-2032) Figure 47. Europe Alpha-1 Antitrypsin Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Alpha-1 Antitrypsin Drugs Sales Share by Application (2021-2032) Figure 49. Europe Alpha-1 Antitrypsin Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Alpha-1 Antitrypsin Drugs Sales Share by Country (2021-2032) Figure 51. China Alpha-1 Antitrypsin Drugs Revenue Share by Type (2021-2032) Figure 52. China Alpha-1 Antitrypsin Drugs Sales Share by Type (2021-2032) Figure 53. China Alpha-1 Antitrypsin Drugs Revenue Share by Application (2021-2032) Figure 54. China Alpha-1 Antitrypsin Drugs Sales Share by Application (2021-2032) Figure 55. Asia Alpha-1 Antitrypsin Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Alpha-1 Antitrypsin Drugs Sales Share by Type (2021-2032) Figure 57. Asia Alpha-1 Antitrypsin Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Alpha-1 Antitrypsin Drugs Sales Share by Application (2021-2032) Figure 59. Asia Alpha-1 Antitrypsin Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Alpha-1 Antitrypsin Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Alpha-1 Antitrypsin Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Alpha-1 Antitrypsin Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Alpha-1 Antitrypsin Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Alpha-1 Antitrypsin Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Alpha-1 Antitrypsin Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Alpha-1 Antitrypsin Drugs Sales Share by Country (2021-2032) Figure 67. Alpha-1 Antitrypsin Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Alpha-1 Antitrypsin Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Parenteral
  • Inhalation
Applications
  • Drugstore
  • Hospital
  • Others
Companies covered
  • Baxter
  • Kamada
  • Grifols
  • CSL Behring
  • Baxalta
  • Arrowhead Research Corporation
  • Applied Genetic Technologies Corp
  • Alnylam Pharmaceuticals
  • Abeona Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alpha-1 Antitrypsin Drugs Market by Type
  3. 1.2.1 Global Alpha-1 Antitrypsin Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Parenteral
  5. 1.2.3 Inhalation
  6. 1.3 Alpha-1 Antitrypsin Drugs Market by Application
  7. 1.3.1 Global Alpha-1 Antitrypsin Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Drugstore
  9. 1.3.3 Hospital
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Alpha-1 Antitrypsin Drugs Market Dynamics
  1. 2.1 Alpha-1 Antitrypsin Drugs Industry Trends
  2. 2.2 Alpha-1 Antitrypsin Drugs Industry Drivers
  3. 2.3 Alpha-1 Antitrypsin Drugs Industry Opportunities and Challenges
  4. 2.4 Alpha-1 Antitrypsin Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alpha-1 Antitrypsin Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region
  3. 3.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alpha-1 Antitrypsin Drugs Sales by Region
  9. 3.4.1 Global Alpha-1 Antitrypsin Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alpha-1 Antitrypsin Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Alpha-1 Antitrypsin Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers
  2. 4.1.1 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alpha-1 Antitrypsin Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers
  6. 4.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alpha-1 Antitrypsin Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alpha-1 Antitrypsin Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alpha-1 Antitrypsin Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alpha-1 Antitrypsin Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alpha-1 Antitrypsin Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Alpha-1 Antitrypsin Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alpha-1 Antitrypsin Drugs Market CR5 and HHI
  16. 4.8.2 2025 Alpha-1 Antitrypsin Drugs Tier 1, Tier 2, and Tier 3
5 Alpha-1 Antitrypsin Drugs Market by Type
  1. 5.1 Global Alpha-1 Antitrypsin Drugs Revenue by Type
  2. 5.1.1 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alpha-1 Antitrypsin Drugs Sales by Type
  6. 5.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alpha-1 Antitrypsin Drugs Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alpha-1 Antitrypsin Drugs Price by Type
6 Alpha-1 Antitrypsin Drugs Market by Application
  1. 6.1 Global Alpha-1 Antitrypsin Drugs Revenue by Application
  2. 6.1.1 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alpha-1 Antitrypsin Drugs Sales by Application
  6. 6.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alpha-1 Antitrypsin Drugs Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alpha-1 Antitrypsin Drugs Price by Application
7 Company Profiles
  1. 7.1 Baxter
  2. 7.1.1 Baxter Company Information
  3. 7.1.2 Baxter Business Overview
  4. 7.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Baxter Alpha-1 Antitrypsin Drugs Product Portfolio
  6. 7.1.5 Baxter Recent Developments
  7. 7.2 Kamada
  8. 7.2.1 Kamada Company Information
  9. 7.2.2 Kamada Business Overview
  10. 7.2.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kamada Alpha-1 Antitrypsin Drugs Product Portfolio
  12. 7.2.5 Kamada Recent Developments
  13. 7.3 Grifols
  14. 7.3.1 Grifols Company Information
  15. 7.3.2 Grifols Business Overview
  16. 7.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Grifols Alpha-1 Antitrypsin Drugs Product Portfolio
  18. 7.3.5 Grifols Recent Developments
  19. 7.4 CSL Behring
  20. 7.4.1 CSL Behring Company Information
  21. 7.4.2 CSL Behring Business Overview
  22. 7.4.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolio
  24. 7.4.5 CSL Behring Recent Developments
  25. 7.5 Baxalta
  26. 7.5.1 Baxalta Company Information
  27. 7.5.2 Baxalta Business Overview
  28. 7.5.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Baxalta Alpha-1 Antitrypsin Drugs Product Portfolio
  30. 7.5.5 Baxalta Recent Developments
  31. 7.6 Arrowhead Research Corporation
  32. 7.6.1 Arrowhead Research Corporation Company Information
  33. 7.6.2 Arrowhead Research Corporation Business Overview
  34. 7.6.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolio
  36. 7.6.5 Arrowhead Research Corporation Recent Developments
  37. 7.7 Applied Genetic Technologies Corp
  38. 7.7.1 Applied Genetic Technologies Corp Company Information
  39. 7.7.2 Applied Genetic Technologies Corp Business Overview
  40. 7.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolio
  42. 7.7.5 Applied Genetic Technologies Corp Recent Developments
  43. 7.8 Alnylam Pharmaceuticals
  44. 7.8.1 Alnylam Pharmaceuticals Company Information
  45. 7.8.2 Alnylam Pharmaceuticals Business Overview
  46. 7.8.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolio
  48. 7.8.5 Alnylam Pharmaceuticals Recent Developments
  49. 7.9 Abeona Therapeutics
  50. 7.9.1 Abeona Therapeutics Company Information
  51. 7.9.2 Abeona Therapeutics Business Overview
  52. 7.9.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolio
  54. 7.9.5 Abeona Therapeutics Recent Developments
8 North America
  1. 8.1 North America Alpha-1 Antitrypsin Drugs Market Size by Type
  2. 8.1.1 North America Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Alpha-1 Antitrypsin Drugs Price by Type (2021-2032)
  5. 8.2 North America Alpha-1 Antitrypsin Drugs Market Size by Application
  6. 8.2.1 North America Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Alpha-1 Antitrypsin Drugs Price by Application (2021-2032)
  9. 8.3 North America Alpha-1 Antitrypsin Drugs Market Size by Country
  10. 8.3.1 North America Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alpha-1 Antitrypsin Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Alpha-1 Antitrypsin Drugs Market Size by Type
  2. 9.1.1 Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alpha-1 Antitrypsin Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Alpha-1 Antitrypsin Drugs Price by Type (2021-2032)
  5. 9.2 Europe Alpha-1 Antitrypsin Drugs Market Size by Application
  6. 9.2.1 Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alpha-1 Antitrypsin Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Alpha-1 Antitrypsin Drugs Price by Application (2021-2032)
  9. 9.3 Europe Alpha-1 Antitrypsin Drugs Market Size by Country
  10. 9.3.1 Europe Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alpha-1 Antitrypsin Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Alpha-1 Antitrypsin Drugs Market Size by Type
  2. 10.1.1 China Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Alpha-1 Antitrypsin Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Alpha-1 Antitrypsin Drugs Price by Type (2021-2032)
  5. 10.2 China Alpha-1 Antitrypsin Drugs Market Size by Application
  6. 10.2.1 China Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Alpha-1 Antitrypsin Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Alpha-1 Antitrypsin Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alpha-1 Antitrypsin Drugs Market Size by Type
  2. 11.1.1 Asia Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alpha-1 Antitrypsin Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Alpha-1 Antitrypsin Drugs Price by Type (2021-2032)
  5. 11.2 Asia Alpha-1 Antitrypsin Drugs Market Size by Application
  6. 11.2.1 Asia Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alpha-1 Antitrypsin Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Alpha-1 Antitrypsin Drugs Price by Application (2021-2032)
  9. 11.3 Asia Alpha-1 Antitrypsin Drugs Market Size by Country
  10. 11.3.1 Asia Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alpha-1 Antitrypsin Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alpha-1 Antitrypsin Drugs Market Size by Type
  2. 12.1.1 SAMEA Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alpha-1 Antitrypsin Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alpha-1 Antitrypsin Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Alpha-1 Antitrypsin Drugs Market Size by Application
  6. 12.2.1 SAMEA Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alpha-1 Antitrypsin Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alpha-1 Antitrypsin Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Alpha-1 Antitrypsin Drugs Market Size by Country
  10. 12.3.1 SAMEA Alpha-1 Antitrypsin Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alpha-1 Antitrypsin Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alpha-1 Antitrypsin Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alpha-1 Antitrypsin Drugs Value Chain Analysis
  2. 13.1.1 Alpha-1 Antitrypsin Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alpha-1 Antitrypsin Drugs Production Mode & Process
  6. 13.2 Alpha-1 Antitrypsin Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alpha-1 Antitrypsin Drugs Distributors
  9. 13.2.3 Alpha-1 Antitrypsin Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst